Cairo – Mubasher: Ibnsina Pharma achieved consolidated net profits of EGP 241.94 million in the first nine months of 2021, up by 20.6% year-on-year (YoY) from EGP 200.61 million, including minority shareholders' rights.
The net sales increased to EGP 15.75 billion in the January-September period, compared to EGP 13.70 billion in the year-ago period, according to a bourse disclosure on Sunday.
As for standalone business, the company logged net profits of EGP 241.27 million in the nine-month period ended 30 September from EGP 200.61 million in the same period in 2020.
In the first half (H1) of 2021, the company recorded net profits of EGP 104.75 million, up from EGP 88.9 million in H1-20.
